Target intelligence / Profile preview

RNA, U6 small nuclear 286, pseudogene (RNU6-286P)

Target
RNU6-286P
Molecular classification
Other, Pseudogene (processed), Non-coding RNA
01

Overview

RNA, U6 small nuclear 286, pseudogene (RNU6-286P) is a **processed pseudogene** corresponding to the U6 small nuclear RNA (snRNA) family[3]. Pseudogenes, including those derived from U6 snRNA, are non-coding genomic elements created by retrotransposition, typically lacking the ability to express functional RNAs or proteins[1][4]. U6 pseudogenes are numerous in the human genome and have been dispersed by mechanisms involving LINE-1 retrotransposon activity, sometimes creating chimeric RNAs or cDNAs, but RNU6-286P itself is not known to have a functional role nor is it considered a therapeutic target[1][3]. While some pseudogenes can be transcribed and might perform regulatory functions, there is no evidence for RNU6-286P functioning as a gene regulator, biomarker, or drug target[3][4]. Its presence mainly reflects evolutionary processes shaping the human genome and expanding non-coding RNA diversity[1][3][4].

Other names
RNU6-286P
02

Biological functions

Other (no established function, possible regulatory RNA roles inferred from pseudogene biology)
03

Disease associations

Other (no evidence for direct disease involvement; U6 snRNA pseudogenes in general may modestly contribute to genetic diversity or transcriptome variation)

Beyond the preview

Go deeper on RNA, U6 small nuclear 286, pseudogene (RNU6-286P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 286, pseudogene (RNU6-286P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call